United Therapeutics Chairperson, CEO Martine Rothblatt reports sale of 9,500 shares for $5.03 million
Share
Listen to the news
United Therapeutics Chairperson, CEO Martine Rothblatt reports sale of 9,500 shares for $5.03 million
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt reported option exercises and share sales on July 20, 2026.
  • A family trust acquired 9,500 common shares via option exercise at USD 135.42.
  • The trust sold 9,500 common shares at weighted-average prices ranging from USD 529.19 to USD 536.41.
  • Trust-held common shares fell to 324,443 following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000102), on July 21, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending